,,iii  #aae? ,,congress  #a/ ,session   
,s4 ,,res4 #caj  ,,9 ,,! ,,s5ate ,,( ,,!
 ,,unit$ ,,/ates  ,octob] #bf1 #bjag    
,mr4 ,casey 7= himself1 ,mr4 ,rubio1    
,mr4 ,blum5?al1 ,mr4 ,durb91 ,mr4       
,boozman1 ,mr4 ,van ,holl51 ,mr4        
,frank51 ,ms4 ,klobu*>1 ,mr4 ,hat*1 ,mr4
 ,m>key1 ,mr4 ,isakson1 ,mr4 ,nelson1   
,mr4 ,k+1 & ,mr4 ,coons7 submitt$ !     
foll[+ resolution2 :i* 0 ref]r$ to !    
,committee on ,=eign ,relations         
,,resolution  ,recogniz+ ! importance ( 
a cont9u$ commitm5t to end+ p$iatric    
,,aids worldwide4  ,:]eas 9 #bjaf       
approximately half ( ! #cf1gjj1jjj p    
liv+ ) human immunodefici5cy virus      
7ref]r$ to 9 ?is preamble z ,,hiv7      
worldwide are wom5 & #b1ajj1jjj are     
*ildr52 ,:]eas ,,hiv is a lead+ cause ( 
dea? worldwide among wom5 ( *ildbe>+    
age2 ,:]eas ne>ly #ij p]c5t (           
,,hiv-positive expectant mo!rs 9 ne$ (  
,,hiv-relat$ s]vices worldwide live 9   
sub-,sah>an ,africa2 ,:]eas wom5 ar\nd !
 _w rely on ess5tial pre- & po/-natal   

c>e to provide scre5+ = diseases su* z  
,,hiv1 & to provide c>e = ! heal? ( wom5
 & infants2 ,:]eas ! usage (            
antiretroviral drugs z prophylaxis c    
r$uce ! likelihood ( "m-to-*ild         
transmission ( ,,hiv to less ?an #e     
p]c5t2 ,:]eas 9 #bjje only #ad p]c5t (  
wom5 receiv$ s]vices = ! prev5tion (    
"m-to-*ild transmission 7ref]r$ to 9 ?is
 preamble z ,,pmtct72 ,:]eas 9 #bjaf1   
#gf p]c5t ( wom5 receiv$ ,,pmtct        
s]vices2 ,:]eas1 s9ce #bjja1 ! numb] (  
*ildr5 born ,,hiv-positive has decreas$ 
by m ?an half2 ,:]eas1 despite increas$ 
ef=ts by ! ,unit$ ,/ates & c\ntries     
ar\nd ! _w1 ov] #djj *ildr5 7 born      
,,hiv-positive ea* day 9 #bjaf2 ,:]eas  
#ij p]c5t ( *ildr5 ) ,,hiv live 9       
sub-,sah>an ,africa2 ,:]eas 9 #bjaf only
 #dc p]c5t ( *ildr5 ) ,,hiv receiv$     
antiretroviral !rapy1 f> bel[ ! p]c5tage
 ( adults receiv+ antiretroviral !rapy2 
,:]eas1 )\t treatm5t1 half ( *ildr5 )   
,,hiv w die by _! second bir?day1 & #hj 
p]c5t by _! fif? bir?day2 ,:]eas1 9     

#bjaf1 #abj1jjj *ildr5 di$ ( causes     
relat$ to acquir$ immune defici5cy      
syndrome 7ref]r$ to 9 ?is preamble z    
,,aids72 ,:]eas1 9 #bjaf1 #bb p]c5t (   
new ,,hiv infections occurr$ 9 "y wom5  
ag$ #ae to #bd2 ,:]eas1 9 sub-,sah>an   
,africa1 "y wom5 acc\nt = #ge p]c5t (   
new annual ,,hiv infections among       
adolesc5ts2 ,:]eas ,,aids is a lead+    
cause ( dea? among adolesc5ts globally2 
,:]eas rese>* ef=ts at ! ,national      
,in/itutes ( ,heal? h l$ to extraord9>y 
break?r\ghs = *ildr5 infect$ ) & at risk
 = ,,hiv2 ,:]eas 9 #bjjb ! ,unit$ ,/ates
 began inve/+ 9 ,,pmtct s]vices by      
e/abli%+ ! ,unit$ ,/ates ,int]national  
,"m & ,*ild ,,hiv ,prev5tion            
,initiative2 ,:]eas1 s9ce #bjjb1 !      
,global ,fund to ,fight ,,aids1         
,tub]culosis & ,mal>ia has support$     
programs t provid$ #d1bjj1jjj           
,,hiv-positive mo!rs ) antiretroviral   
drug prophylaxis = ,,pmtct2 ,:]eas 9    
fiscal ye> #bjaf1 ! ,unit$ ,/ates       
,presid5t's ,em]g5cy ,plan = ,,aids     

,relief 7ref]r$ to 9 ?is preamble z     
,,pepf>7 support$ ,,hiv te/+ & c\nsel+ =
 m ?an #aa1ejj1jjj pregnant wom51 &     
provid$ antiretroviral drug prophylaxis 
= ,,pmtct1 all[+ ne>ly #b1jjj1jjj babies
 to be born free ( ,,hiv2 ,:]eas 9 #bjad
 ,,pepf> ann\nc$ ! ,accel]at+ ,*ildr5's 
,treatm5t ,initiative1 a #b-ye> ef=t t  
w\ld d\ble ! numb] ( ,,hiv-positive     
*ildr5 receiv+ treatm5t 9 #aj high-burd5
 c\ntries2 ,:]eas ! ,,pepf> ,,dreams    
initiative is work+ to r$uce new ,,hiv  
infections 9 girls & "y wom5 9 #aj      
sub-,sah>an c\ntries2 ,:]eas e "m %\ld h
 ! opportunity to fight = ! life ( h]   
*ild2 & ,:]eas e *ild & adolesc5t %\ld h
 access to m$ic9e to lead a long &      
heal?y life3 ,n[1 !re=e1 be x  ,t !     
,s5ate-- 7#a7 recognizes t ! prev5tion (
 "m-to-*ild transmission ( human        
immunodefici5cy virus 7ref]r$ to 9 ?is  
resolv+ clause z ,,hiv7 is critical to  
/opp+ ! spread ( ,,hiv worldwide2  7#b7 
applauds ! lead]%ip ( ! ,unit$ ,/ates = 
ef=ts to elim9ate new p$iatric ,,hiv    

infections & to exp& p$iatric treatm5t  
?r\gh programs & rese>*2  7#c7          
recognizes t = m ?an #ac ye>s1 ! fight  
to elim9ate p$iatric ,,hiv worldwide has
 be5 a priority 9 ! response ( ! ,unit$ 
,/ates to global acquir$ immune         
defici5cy syndrome 7ref]r$ to 9 ?is     
resolv+ clause z ,,aids71 & calls on !  
lead]%ip ( ! ,unit$ ,/ates 9 ?is area to
 cont9ue2  7#d7 supports provid+        
adolesc5ts ) ! evid5ce-bas$ approa*es   
necess>y to prev5t new ,,hiv infections2
  7#e7 supports provid+ wom5 & *ildr5 ) 
,,hiv c\nsel+ & te/+ s]vices :]e        
practicable1 & scal+ up access to       
s]vices & m$ic9es t prev5t "m-to-*ild   
transmission ( ,,hiv & ensure           
,,hiv-positive mo!rs survive & ?rive2   
7#f7 supports exp&+ treatm5t = ,,hiv =  
*ildr5 & adolesc5ts1 includ+ provid+    
great] access to m efficaci\s           
antiretroviral drug regim5s1 age        
appropriate s]vices1 & support = !      
c>egiv]s ( *ildr5 & adolesc5ts2 &  7#g7 
recommits ! ,unit$ ,/ates-- 7,a7 to lead

 ! _w to end ,,aids2  7,b7 to elim9ate  
new p$iatric ,,hiv infections worldwide2
 &  7,c7 to support wom51 *ildr51       
adolesc5ts1 & families infect$ & affect$
 by ,,hiv4